• Home
  • Stock
  • Piramal Pharma Fundamental Analysis
  • Piramal Pharma Fundamental Analysis

Piramal Pharma fundamental analysis

PPLPHARMA

HealthcareLarge

189.24

0.40 (-0.21%)
Last updated on 21 Nov, 2025 | 12:23 IST
BUYSELL

The current prices are delayed, login to your account for live prices

Piramal Pharma Fundamentals

P/E Ratio

0

P/B Ratio

3.11

Div. Yield

0.07

Sector P/E

37.59

Sector P/B

3.65

Sec. Div. Yield

0.57

  • Piramal Pharma Fundamentals is currently trading with a P/E Ratio of 0, compared to the sector average of 37.59. Its P/B Ratio stands at 3.11, while the sector’s is 3.65. In terms of returns, the stock offers a Dividend Yield of 0.07%, which is than the sector’s 0.57%.

Piramal Pharma Score Card

  • Price

    Attractive

  • Growth

    Good

  • Quality

    Poor

  • Management

    Average

  • On its scorecard, Piramal Pharma reflects: Price – Attractive, Growth – Good, Quality – Poor, and Management – Average. Together, these indicators provide a structured view of the company’s fundamentals.